Search research articles
Contact Us
Filters
Showing results (121-130 of 134) with videos related to
Page
of 14
Sort By:
JAAD International
|
August 19, 2021
Effectiveness and tolerability of guselkumab in patients with psoriasis: A longitudinal Belgian retrospective multicenter study
Pierre-Dominique Ghislain, Valérie Failla, Jo Lambert, et al.
The Lancet. Gastroenterology & Hepatology
|
January 13, 2022
Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives
Konstantinos Papamichael, Waqqas Afif, David Drobne, et al.
The Journal of Investigative Dermatology
|
February 18, 2011
Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset
Ying Jin, Stanca A Birlea, Pamela R Fain, et al.
JAMA Dermatology
|
September 14, 2017
Safety of Systemic Agents for the Treatment of Pediatric Psoriasis
Inge M G J Bronckers, Marieke M B Seyger, Dennis P West, et al.
JAMA Dermatology
|
February 6, 2020
A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents
Inge M G J Bronckers, Amy S Paller, Dennis P West, et al.
Nature Genetics
|
June 8, 2010
Common variants in FOXP1 are associated with generalized vitiligo
Ying Jin, Stanca A Birlea, Pamela R Fain, et al.
Communications Medicine
|
March 6, 2026
Patient-specific alterations in blood plasma cfRNA profiles enable accurate classification of cancer patients and controls
Annelien Morlion, Philippe Decruyenaere, Kathleen Schoofs, et al.
The New England Journal of Medicine
|
April 23, 2010
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo
Ying Jin, Stanca A Birlea, Pamela R Fain, et al.
Nature Genetics
|
May 8, 2012
Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo
Ying Jin, Stanca A Birlea, Pamela R Fain, et al.
The Journal of Allergy and Clinical Immunology
|
October 19, 2020
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study
Satveer K Mahil, Nick Dand, Kayleigh J Mason, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 134) with videos related to
Sort By:
Page
of 14
JAAD International
|
August 19, 2021
Effectiveness and tolerability of guselkumab in patients with psoriasis: A longitudinal Belgian retrospective multicenter study
Pierre-Dominique Ghislain, Valérie Failla, Jo Lambert, et al.
The Lancet. Gastroenterology & Hepatology
|
January 13, 2022
Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives
Konstantinos Papamichael, Waqqas Afif, David Drobne, et al.
The Journal of Investigative Dermatology
|
February 18, 2011
Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset
Ying Jin, Stanca A Birlea, Pamela R Fain, et al.
JAMA Dermatology
|
September 14, 2017
Safety of Systemic Agents for the Treatment of Pediatric Psoriasis
Inge M G J Bronckers, Marieke M B Seyger, Dennis P West, et al.
JAMA Dermatology
|
February 6, 2020
A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents
Inge M G J Bronckers, Amy S Paller, Dennis P West, et al.
Nature Genetics
|
June 8, 2010
Common variants in FOXP1 are associated with generalized vitiligo
Ying Jin, Stanca A Birlea, Pamela R Fain, et al.
Communications Medicine
|
March 6, 2026
Patient-specific alterations in blood plasma cfRNA profiles enable accurate classification of cancer patients and controls
Annelien Morlion, Philippe Decruyenaere, Kathleen Schoofs, et al.
The New England Journal of Medicine
|
April 23, 2010
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo
Ying Jin, Stanca A Birlea, Pamela R Fain, et al.
Nature Genetics
|
May 8, 2012
Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo
Ying Jin, Stanca A Birlea, Pamela R Fain, et al.
The Journal of Allergy and Clinical Immunology
|
October 19, 2020
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study
Satveer K Mahil, Nick Dand, Kayleigh J Mason, et al.
Page
of 14